110 related articles for article (PubMed ID: 37871262)
1. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
[TBL] [Abstract][Full Text] [Related]
2. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
[TBL] [Abstract][Full Text] [Related]
3. Partial SAA patients benefit from delayed response of IST.
Wang T; Wang C; Liu C; Shao Z; Fu R
Front Immunol; 2023; 14():1067977. PubMed ID: 36845107
[TBL] [Abstract][Full Text] [Related]
4. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D
Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976
[TBL] [Abstract][Full Text] [Related]
5. Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review.
Yang Y; Ji J; Tang Z; Han B
Front Oncol; 2021; 11():614965. PubMed ID: 33981596
[No Abstract] [Full Text] [Related]
6. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
[TBL] [Abstract][Full Text] [Related]
7. Progress in medical therapy in aplastic anemia: why it took so long?
Scheinberg P
Int J Hematol; 2024 Mar; 119(3):248-254. PubMed ID: 38403842
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Zhang Y; Li J; Li X; Geng Q; Xie Y; Zhang G; Wei M; Ma Y
Syst Rev; 2024 Apr; 13(1):101. PubMed ID: 38576005
[TBL] [Abstract][Full Text] [Related]
9. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults.
Piekarska A; Pawelec K; Szmigielska-Kapłon A; Ussowicz M
Front Immunol; 2024; 15():1378432. PubMed ID: 38646536
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
McQuilten Z; Heritier S; Fox L; Fox V; Young L; Blombery P; Cunningham I; Curnow J; Higgins A; Hiwase DK; Filshie R; Firkin F; Lacaze P; Mason K; Mills AK; Pepperell D; Patil S; Stevenson W; Szer J; Waters N; Wilson K; Ting S; Wood E
BMJ Open; 2024 Jan; 14(1):e076246. PubMed ID: 38238183
[TBL] [Abstract][Full Text] [Related]
11. Upfront Umbilical Cord Blood Transplantation Versus Immunosuppressive Therapy for Pediatric Patients With Idiopathic Severe Aplastic Anemia.
Zhao X; Lv W; Song K; Yao W; Li C; Tang B; Wan X; Geng L; Sun G; Qiang P; Liu H; Liu H; Sun Z
Transplant Cell Ther; 2024 Apr; 30(4):442.e1-442.e13. PubMed ID: 38278182
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Outcomes of Matched and Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation with Different Anti-Thymocyte Globulin Formulations: A Retrospective, Double-Centre Experience on Behalf of the Polish Adult Leukemia Group.
Giordano U; Mordak-Domagała M; Sobczyk-Kruszelnicka M; Giebel S; Gil L; Dudek KD; Dybko J
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791969
[TBL] [Abstract][Full Text] [Related]
13. The evolution and impact of sarcopenia in severe aplastic anaemia survivors following allogeneic haematopoietic cell transplantation.
Chen D; Yuan Z; Guo Y; Liu W; Cheng Z; Ye L; Mo W; Wei X
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1094-1107. PubMed ID: 38526005
[TBL] [Abstract][Full Text] [Related]
14. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Marsh J; Socie G; Tichelli A; Schrezenmeier H; Hochsmann B; Risitano AM; Fuehrer M; Bekassy AN; Korthof ET; Locasciulli A; Ljungman P; Bacigalupo A; Camitta B; Young NS; Passweg J;
Br J Haematol; 2010 Aug; 150(3):377-9. PubMed ID: 20528874
[No Abstract] [Full Text] [Related]
15. Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.
Aggarwal N; Manley AL; Shalhoub R; Durrani J; Rios O; Lotter J; Patel BA; Wu CO; Young NS; Groarke EM
Am J Hematol; 2023 Jun; 98(6):932-939. PubMed ID: 37021397
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
Kulasekararaj A; Cavenagh J; Dokal I; Foukaneli T; Gandhi S; Garg M; Griffin M; Hillmen P; Ireland R; Killick S; Mansour S; Mufti G; Potter V; Snowden J; Stanworth S; Zuha R; Marsh J;
Br J Haematol; 2024 Mar; 204(3):784-804. PubMed ID: 38247114
[TBL] [Abstract][Full Text] [Related]
17. The Reconstitution of T-cells after Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Congenital Amegakaryocytic Thrombocytopenia (CAMT).
Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Tajik N; Delbandi AA; Delavari S; Shekarabi M; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2024; 24(2):265-272. PubMed ID: 37526450
[TBL] [Abstract][Full Text] [Related]
18. Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia.
Nakamura Y; Zaimoku Y; Yamaguchi H; Yamazaki H; Kanaya M; Uchida N; Doki N; Sakurai M; Hiramoto N; Kako S; Onizuka M; Onodera K; Maruyama Y; Ohigashi H; Nishida T; Yoshihara S; Matsuoka KI; Eto T; Kanda Y; Fukuda T; Atsuta Y; Onishi Y
Ann Hematol; 2024 May; ():. PubMed ID: 38750374
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy After Hematopoietic Cell Transplant in Severe Aplastic Anemia: Report of 2 Cases.
Jasak K; Jabiry-Zieniewicz Z; Stelmach D; Knap-Wielgus W; Korzeb B; Szpotańska-Sikorska M
Transplant Proc; 2024 May; 56(4):910-911. PubMed ID: 38729833
[TBL] [Abstract][Full Text] [Related]
20. Eltrombopag combined with immunosuppressive therapy for pediatric severe aplastic anemia.
Yang B; Fu L; Li H; Chen H; Zhang R; Yao J; Zhang L; Wu R; Ma J
Pediatr Res; 2024 May; ():. PubMed ID: 38822136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
